Stem Cell
UCLA's Stem Cell Core, in partnership with Georgia Tech, provides end-to-end CRISPR genome engineering, advanced pluripotent stem cell characterization and differentiation, and induced pluripotent stem cell (iPSC) reprogramming services. We support high-quality stem cell research through validated, reproducible workflows and collaborates with academic and industry partners to advance studies in development, disease modeling, and regenerative medicine.
Services
Integration Free iPSC Reprogramming
- Human fibroblasts
- Peripheral blood mononuclear cells (PBMCs)
Pluripotent Stem Cell Characterization & Differentiation
- Whole Genome Sequencing–Based Genomic Stability Assay
- Immunocytochemistry for pluripotency markers (OCT4, SSEA4)
- Trilineage differentiation assay
- Mycoplasma testing
CRISPR Genome Engineering
- Gene knockout
- Safe harbor locus engineering (e.g. AAVS1 site)
- Inducible Knockout/CRISPR activation/CRISPR inhibition
- Vector/gRNA design & cloning
Location
University of California, Los Angeles (UCLA)